September 1, 2018Open Access

Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

NFL chain has significantly increased in MS patients, which substantially strengthens the clinical evidence of the NFL in MS. The NFL may be used as a prognostic biomarker to monitor disease progression, disease activity, and treatment efficacy in the future.

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Cai et al. (Sat,) studied this question.

synapsesocial.com/papers/69dec9a5499d77a496b0cd4a https://doi.org/https://doi.org/10.2147/ndt.s173280

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Neurofilament light chain level is a weak risk factor for the development of MS2016 · 108 citations
2CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome2012 · 87 citations
3Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses2010 · 17,680 citations
4Accumulation of cortical hyperphosphorylated neurofilaments as a marker of neurodegeneration in multiple sclerosis2012 · 31 citations
5Extreme Stability of Chitotriosidase in Cerebrospinal Fluid makes it a Suitable Marker for Microglial Activation in Clinical Trials2012 · 24 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo